105 related articles for article (PubMed ID: 9378540)
1. Suppression of metastatic potential and up-regulation of gelatinases and uPA in LLC by protracted in vivo treatment with dacarbazine or razoxane.
Garbisa S; Onisto M; Peron A; Perissin L; Rapozzi V; Zorzet S; Giraldi T
Int J Cancer; 1997 Sep; 72(6):1056-61. PubMed ID: 9378540
[TBL] [Abstract][Full Text] [Related]
2. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats.
Kido A; Tsutsumi M; Iki K; Takahama M; Tsujiuchi T; Morishita T; Tamai S; Konishi Y
Cancer Lett; 1999 Apr; 137(2):209-16. PubMed ID: 10374843
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
6. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
7. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
8. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Wang M; Fudge K; Rhim JS; Stearns ME
Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
10. [Effects of TIMP-2 gene transfection on biological behaviors of a metastatic human lung carcinoma cell line].
Li H; Fang W; Shi Z
Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):652-6. PubMed ID: 9772531
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Sehgal I; Thompson TC
Cancer Res; 1998 Oct; 58(19):4288-91. PubMed ID: 9766654
[TBL] [Abstract][Full Text] [Related]
12. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
Kugler A; Hemmerlein B; Thelen P; Kallerhoff M; Radzun HJ; Ringert RH
J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.
Okada T; Li J; Kodaka M; Okuno H
Clin Exp Metastasis; 1998 Apr; 16(3):267-74. PubMed ID: 9568644
[TBL] [Abstract][Full Text] [Related]
14. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
15. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig.
Menino AR; Hogan A; Schultz GA; Novak S; Dixon W; Foxcroft GH
Dev Genet; 1997; 21(1):68-74. PubMed ID: 9291582
[TBL] [Abstract][Full Text] [Related]
16. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Gokaslan ZL; Chintala SK; York JE; Boyapati V; Jasti S; Sawaya R; Fuller G; Wildrick DM; Nicolson GL; Rao JS
Clin Exp Metastasis; 1998 Nov; 16(8):721-8. PubMed ID: 10211985
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
18. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M
J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409
[TBL] [Abstract][Full Text] [Related]
19. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 modulates the expression of gelatinase A and B in monocytic cells.
Kalebic T; Masiero L; Onisto M; Garbisa S
Biochem Biophys Res Commun; 1994 Dec; 205(2):1243-9. PubMed ID: 7802656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
